Thompson Davis & Co., Inc. Global Blood Therapeutics, Inc. Call Options Transaction History
Thompson Davis & Co., Inc.
- $132 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GBT
# of Institutions
8Shares Held
288KCall Options Held
0Put Options Held
0-
Roosevelt Investment Group LLC147KShares$00.72% of portfolio
-
Jefferies Group LLC New York, NY46.3KShares$00.03% of portfolio
-
S. Muoio & Co. LLC New York, NY40.7KShares$03.66% of portfolio
-
Taylor Wealth Management Partners Boston, MA27.9KShares$00.51% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA26KShares$01.83% of portfolio
About Global Blood Therapeutics, Inc.
- Ticker GBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,476,200
- Market Cap $4.62B
- Description
- Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...